EPISODE · Apr 9, 2026 · 34 MIN
The Blood Test That Could Detect Alzheimer’s Years Before Symptoms | Mike Banville - CEO, ALZpath
from Progress, Potential, and Possibilities Podcast / Show · host Ira Pastor / Mike Banville
Send us Fan MailWhat if a simple blood test could detect Alzheimer’s years—maybe even decades—before symptoms ever appear?Mike Banville is the Chief Executive Officer of ALZpath ( https://alzpath.bio/ ), a company at the forefront of transforming how Alzheimer’s disease is detected and monitored through cutting-edge blood-based diagnostics.Mike is a seasoned global executive with a track record of scaling businesses, driving operational transformation, and executing strategic growth through both organic expansion and acquisitions. Prior to ALZpath, he served as CEO of SSB - doubling revenue and shifting the business to a predominantly recurring revenue model.Earlier in his career, Mike spent over two decades at IHS Markit, where he held multiple senior leadership roles across strategy, sales, marketing, and global operations. There, he helped scale the Telecommunications, Media, and Technology division through acquisitions and product integration, while also leading global offshoring strategy and climate-focused market development initiatives.Mike has also led and turned around companies in digital health and athlete development, bringing a consistent focus on data, analytics, and scalable platforms.Now at ALZpath, Mike is applying that same operational and strategic expertise to one of the most urgent challenges in medicine - enabling earlier, more accessible detection of Alzheimer’s disease through innovative biomarker technologies, like pTau217, helping accelerate research, improve clinical care, and ultimately impact millions of patients worldwide.#Alzheimers #AlzheimersDisease #Dementia #BrainHealth #Longevity #Biotech #HealthcareInnovation #Diagnostics #BloodTest #EarlyDetection #Neuroscience #Neurodegeneration #PrecisionMedicine #FutureOfMedicine #MedTech #Biomarkers #TauProtein #pTau217 #StartupCEO #BiotechCEO #HealthcarePodcast #MedicalBreakthrough #AgingResearch #CognitiveHealth #LifeSciencesSupport the show
What this episode covers
Send us Fan Mail What if a simple blood test could detect Alzheimer’s years—maybe even decades—before symptoms ever appear? Mike Banville is the Chief Executive Officer of ALZpath ( https://alzpath.bio/ ), a company at the forefront of transforming how Alzheimer’s disease is detected and monitored through cutting-edge blood-based diagnostics. Mike is a seasoned global executive with a track record of scaling businesses, driving operational transformation, and executing strategic growth thro...
NOW PLAYING
The Blood Test That Could Detect Alzheimer’s Years Before Symptoms | Mike Banville - CEO, ALZpath
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m